FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening
FBLN2启动子高甲基化:通过高通量CpG岛筛选,可作为透明细胞肾细胞癌的负性预后生物标志物和抗PD-1疗效预测因子
期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-025-01981-2
Liao, Wenfeng; Yu, Lianzi; Zhang, Lufang; Shao, Jie; Li, Guanhua; Hua, Jialei; Zhao, Shuya; Jia, Li; Han, Yawei; Zhang, Aimin; Yao, Xin; Li, Yueguo; Dong, Dong